Growth hormone as a risk for premature mortality in healthy subjects: Data from the Paris prospective study

British Medical Journal

Volumn 316, Issue 7138, 1998, Pages 1132-1133

  Maison, Patrick ^a,d   Balkau, Beverley ^a   Simon, Dominique ^a   Chanson, Philippe ^b   Rosselin, Gabriel ^c   Eschwège, Eveline ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; ARTICLE; CANCER; CANCER MORTALITY; CARDIOVASCULAR DISEASE; GROWTH HORMONE BLOOD LEVEL; HUMAN; MALE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0032507431     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7138.1132     Document Type: Article

References (5)

1. Rosen T, Bengtsson BA: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-8.
2. Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B. Epidemiology and long term survival in acromegaly. Acta Med Scand 1988;223:327-35.
3. Balkau B, Eschwège E, Papoz L, Richard JL, Claude JR, Warnet JM, et al. Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ 1993;307:295-9.
4. Rosselin G, Assan R, Yalow RS, Berson SA. Separation of antibody bound and unbound peptide hormone labelled with iodine 131 by talcum powder and precipitated silica. Nature 1966;212:355-7.
5. Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994;15:555-73.